Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%.

Dubiner HB, Noecker R.

Clin Ophthalmol. 2012;6:525-31. doi: 10.2147/OPTH.S30690. Epub 2012 Mar 29.

PMID:
22536047
[PubMed]
Free PMC Article
3.

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.

PMID:
17415690
[PubMed - indexed for MEDLINE]
4.

A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.

Denis P, Andrew R, Wells D, Friren B.

Eur J Ophthalmol. 2006 May-Jun;16(3):407-15.

PMID:
16761242
[PubMed - indexed for MEDLINE]
5.

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.

Fellman RL, Sullivan EK, Ratliff M, Silver LH, Whitson JT, Turner FD, Weiner AL, Davis AA; Travoprost Study Group.

Ophthalmology. 2002 May;109(5):998-1008.

PMID:
11986110
[PubMed - indexed for MEDLINE]
6.

Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.

Dubiner HB, Sircy MD, Landry T, Bergamini MV, Silver LH, Darell Turner F, Robertson S, Andrew RM, Weiner A, Przydryga J.

Clin Ther. 2004 Jan;26(1):84-91.

PMID:
14996520
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.

Schuman JS, Katz GJ, Lewis RA, Henry JC, Mallick S, Wells DT, Sullivan EK, Landry TA, Bergamini MV, Robertson SM.

Am J Ophthalmol. 2005 Aug;140(2):242-50.

PMID:
16086946
[PubMed - indexed for MEDLINE]
9.
10.

24-hour intraocular pressure control obtained with evening- versus morning-dosed travoprost in primary open-angle glaucoma.

Konstas AG, Mikropoulos D, Kaltsos K, Jenkins JN, Stewart WC.

Ophthalmology. 2006 Mar;113(3):446-50.

PMID:
16513458
[PubMed - indexed for MEDLINE]
11.

Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.

García-Feijoo J, Martínez-de-la-Casa JM, Castillo A, Méndez C, Fernández-Vidal A, García-Sánchez J.

Curr Med Res Opin. 2006 Sep;22(9):1689-97.

PMID:
16968572
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension.

Teus MA, Miglior S, Laganovska G, Volksone L, Romanowska-Dixon B, Gos R, Holló G.

Clin Ophthalmol. 2009;3:629-36. Epub 2009 Nov 16. Erratum in: Clin Ophthalmol. 2011;5:971.

PMID:
19997566
[PubMed]
Free PMC Article
13.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886
[PubMed - indexed for MEDLINE]
14.
15.

Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma.

Gandolfi S, Paredes T, Goldberg I, Coote M, Wells A, Volksone L, Pillai MR, Stalmans I, Denis P; Travoprost Bak-Free Clinical Study Group.

Eur J Ophthalmol. 2012 Jan-Feb;22(1):34-44. doi: 10.5301/ejo.5000001.

PMID:
22167541
[PubMed - indexed for MEDLINE]
16.

Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.

Holló G, Kóthy P.

Curr Med Res Opin. 2008 Jun;24(6):1755-61. doi: 10.1185/03007990802159273. Epub 2008 May 13.

PMID:
18479590
[PubMed - indexed for MEDLINE]
17.

Duration of IOP reduction with travoprost BAK-free solution.

Gross RL, Peace JH, Smith SE, Walters TR, Dubiner HB, Weiss MJ, Ochsner KI.

J Glaucoma. 2008 Apr-May;17(3):217-22. doi: 10.1097/IJG.0b013e31815a3472.

PMID:
18414108
[PubMed - indexed for MEDLINE]
18.

The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.

Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, Bergamini MV.

Am J Ophthalmol. 2005 Jul;140(1):1-7.

PMID:
15990081
[PubMed - indexed for MEDLINE]
19.

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.

Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK; International Travoprost Study Group.

J Glaucoma. 2001 Oct;10(5):414-22.

PMID:
11711841
[PubMed - indexed for MEDLINE]
20.

Travoprost in the management of open-angle glaucoma and ocular hypertension.

Denis P, Covert D, Realini A.

Clin Ophthalmol. 2007 Mar;1(1):11-24.

PMID:
19668462
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk